SEC filings,
explained daily
We read SEC filings so you don't have to. Track IPOs, corporate events, and executive trades — all sourced directly from official SEC disclosures.
Start ExploringWhat you'll find here
Track IPOs, events, and company reports
Read & Learn
Latest insights and market analysis
April Fools? No Joke: Markets Rocket as AI Giants and Biotech Breakthroughs Steal the Show
The markets are in full 'risk-on' mode today, with the Nasdaq surging over 5% as massive IPO news from OpenAI and SpaceX captures investor imagination. While geopolitical headlines simmer in the background, breakthroughs in weight-loss pills and a wave of AI infrastructure funding are keeping the bulls firmly in the driver's seat.
Q1 Ends with a Bang: Markets Rally on Peace Hopes While AI Giants Face a Reality Check
Global markets soared to close out the first quarter as geopolitical tensions cooled, but the tech sector hit a speed bump as investors demanded proof of AI profitability. From Microsoft’s historic slump to OpenAI’s massive funding haul, it’s a tale of two markets as we head into April.
From the Blog
Stories and insights from SEC filing data
When a 'Strategy Change' 8-K Means a Company Is Becoming Someone Else
NovaBay Pharmaceuticals filed what our pipeline classified as a Strategy Change event this week. That label barely covers it — the company is abandoning its pharmaceutical business entirely and reinventing itself as a crypto holding company.
Getty Images Got a NYSE Delisting Warning. The Filing Explains Why.
The company that defined premium stock photography — and then tried to profit from the AI wave eroding it — just received a NYSE non-compliance notice. The stock is under $1. The SEC filing tells the story the press releases didn't.
Block & Atlassian: The Layoff Playbook Everyone Is Running Right Now
Jack Dorsey halved Block's workforce and the market cheered loudly. Atlassian copied the script two weeks later. Both cited AI. Both buried hundreds of millions in restructuring charges in footnotes. But only one story has a twist ending.
SpyGlass Pharma: How to Actually Read Insider Trading Signals
Our data showed 15 insiders buying $221M in SpyGlass Pharma on a single day. That sounds exciting — but once you understand what was actually happening, it becomes something more useful: a lesson in reading Form 4 filings the right way.
How it works
Simple process, powerful results
EDGAR crawled daily
Our pipeline downloads new filings from SEC EDGAR every morning
Structured summaries generated
Gemini 2.5 Flash extracts key fields and generates plain-English summaries from filing text
Published as static pages
Summaries are compiled into fast, static pages — no login, no paywall, no finance degree required